Table 2. Cox-proportional hazards regression model for cardiovascular diseases, cerebrovascular diseases, cardio-cerebrovascular diseases, cardio-cerebrovascular diseases-related death, or all-cause death according to the TyG index quartile.
| Total | Men | Women | |
| The primary outcomes (Cardio-cerebrovascular diseases and all-cause mortality) | Q1 | Reference | Reference |
| Q2 | 1.062 (0.981−1.150) | 1.099 (0.986−1.226) | |
| Q3 | 1.110 (1.024−1.204) | 1.046 (0.938−1.166) | |
| Q4 | 1.151 (1.058−1.252) | 1.063 (0.954−1.184) | |
| Subgroups | Men | Women | |
| Cardiovascular diseases | Q1 | Reference | Reference |
| Q2 | 1.114 (0.969−1.282) | 1.238 (1.017−1.508) | |
| Q3 | 1.185 (1.031−1.363) | 1.183 (0.971−1.440) | |
| Q4 | 1.232 (1.068−1.422) | 1.238 (1.018−1.505) | |
| Ischemic cerebrovascular diseases | Q1 | Reference | Reference |
| Q2 | 1.005 (0.850−1.187) | 1.040 (0.821−1.316) | |
| Q3 | 1.225 (1.041−1.441) | 1.226 (0.981−1.532) | |
| Q4 | 1.232 (1.039−1.460) | 1.312 (1.054−1.634) | |
| Hemorrhagic cerebrovascular diseases | Q1 | Reference | Reference |
| Q2 | 1.126 (0.781−1.625) | 0.972 (0.642−1.472) | |
| Q3 | 0.937 (0.634−1.384) | 0.554 (0.347−0.884) | |
| Q4 | 0.905 (0.602−1.360) | 0.452 (0.278−0.734) | |
| Other cerebrovascular diseases | Q1 | Reference | Reference |
| Q2 | 1.007 (0.833−1.218) | 0.956 (0.789−1.160) | |
| Q3 | 0.949 (0.780−1.155) | 0.943 (0.778−1.143) | |
| Q4 | 0.971 (0.793−1.189) | 0.883 (0.727−1.073) | |
| Cardio-cerebrovascular diseases- | Q1 | Reference | Reference |
| related deaths | Q2 | 1.231 (0.778−1.947) | 0.908 (0.405−2.035) |
| Q3 | 1.157 (0.713−1.876) | 1.452 (0.708−2.976) | |
| Q4 | 1.167 (0.698−1.954) | 1.242 (0.601−2.566) | |
| All-cause deaths | Q1 | Reference | Reference |
| Q2 | 1.048 (0.911−1.205) | 1.216 (0.936−1.580) | |
| Q3 | 1.105 (0.955−1.278) | 1.009 (0.776−1.313) | |
| Q4 | 1.063 (0.907−1.245) | 0.990 (0.763−1.284) |
Adjusted for age, smoking status (ever and never smokers), drinking status (rare, sometimes, and often) and physical activity (rare, sometimes, and regular), body mass index, systolic blood pressure, LDL-C, economic status (low, middle, and high), and anti-hypertensive medications.
Cerebrovascular diseases are as follows: ischemic cerebrovascular diseases, I63 (cerebral infarction), I65 (occlusion and stenosis of precerebral arteries, not resulting in cerebral infarction), and I66 (occlusion and stenosis of cerebral arteries, not resulting in cerebral infarction); hemorrhagic cerebrovascular diseases, I60 (subarachnoid hemorrhage), I61 (intracranial hemorrhage), and I62 (other nontraumatic intracranial hemorrhage); and other cerebrovascular diseases, I64 (stroke, not specified as hemorrhage or infarction), I67 (other cerebrovascular diseases), I68 (cerebrovascular disorders in diseases classified elsewhere), and I69 (sequelae of cerebrovascular disease).